🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Because of the amazing response to our first episode of the Good Medicine Podcast yesterday, we’ve got a surprise for you—BONUS EPISODE! In this solo episode, I dive into one of the most frustrating questions in healthcare 👉 Listen now: youtu.be/fqmusawnLc4

If you haven’t tuned in yet, now’s the perfect time: 🔹 Episode 1 features Dr. Joshua Schiffman and his fascinating work with elephants and cancer 🔹 Episode 2 breaks down why drug prices are so high! 📺 Watch both episodes on YouTube: youtube.com/@GoodMedicineP…

Kelvyn Cullimore sits down with Dr. David Bearss to talk about his journey, his current work, and where he sees the future of medical care headed. Tune in tomorrow to catch the full episode and get to know the man behind the mission. Here’s a sneak peek.

This week on the Good Medicine Podcast, Kelvyn Cullimore flips the script and interviews Dr. David Bearss. Get to know the scientist behind the mic—his journey, his work, and his vision for the future of healthcare. Go check out the full episode: youtube.com/watch?v=p5zL4R…

Dave shares what he’s working on right now — and it’s big. If you haven’t checked out yesterday’s episode yet, this is your reminder! Hear the full story on the podcast — available everywhere you listen. youtube.com/watch?v=p5zL4R…

This week on the Good Medicine Podcast, Dr. Bearss sits down with Dr, Chris Gibson. They discuss the intersection of biology and machine learning. Tune in tomorrow morning to listen to the full podcast!

This week, Dr. Bearss sits down with Dr. Chris Gibson to discuss biology, machine learning, and how Recursion is using huge proprietary datasets and pharma’s most powerful supercomputer to transform drug development. Available wherever you get your podcasts!

Yesterday we released our conversation with Chris Gibson CEO of Recursion-and it’s packed with insight We talk about innovation, leadership, the intersection of technology and healthcare, and what it takes to build a company that's changing the game Watch now on all platforms

New podcast dropping tomorrow! What really happened with Trump’s “Most Favored Nation” drug pricing rule? Dr. Bearss breaks down what it aimed to do and what it means for the future of drug costs in America. Follow us and be the first to listen.

New episode of Good Medicine! Dr. Bearss takes on Trump’s “Most Favored Nation” drug pricing rule - What is the MFN rule trying to accomplish? - Why did it stir strong reactions across the industry? - And what could it signal for future drug pricing? Link in description

Missed our latest episode? Dr. Bearss breaks down Trump’s “Most Favored Nation” drug pricing rule. If you care about healthcare costs, policy, or the science behind drug pricing — don’t skip this one. Links in description

Tomorrow on Good Medicine: Dr. Bearss sits down with Dr. Ryan Watts, neuroscientist and CEO of Denali Therapeutics, to talk about one of medicine’s biggest frontiers: treating neurodegenerative disease. New episode drops tomorrow!

This week, Dr. Bearss sits down with Dr. Ryan Watts, CEO of Denali Therapeutics, to unpack: -Why the brain is so hard to treat -How Denali is breaking through the blood-brain barrier -And what the future of neurodegenerative medicine could look like Link in description!

Brain disease is one of medicine’s greatest challenges — but new hope is emerging. In our latest episode, Dr. Bearss talks with Dr. Ryan Watts of Denali Therapeutics about what it takes to develop real treatments for neurodegeneration. Link in description

This week on Good Medicine, Dr. David Bearss explores the powerful and sometimes controversial roles of the FDA and NIH in shaping healthcare. What’s working? What needs to change? And who really decides? Tune in tomorrow to hear Dave break it all down

New episode is live! Dr. David Bearss dives into the FDA and NIH—two institutions at the center of innovation, safety, and public trust in medicine. Watch now on YouTube: youtube.com/@GoodMedicineP… Available on Spotify & Apple Podcasts

Why do some people see the FDA and NIH as protectors—and others see them as blockers? In this week’s Good Medicine, Dave explores the growing debate over how these institutions operate, and what needs to evolve to keep pace with modern science. Catch the full conversation now!

This week on Good Medicine, Mark Paul reflects on decades of leadership in the medical device industry. From operating rooms to breakthrough innovations, he shares hard-won lessons, industry insights, and advice for the next generation. New episode drops tomorrow!

New episode is live! In this week’s Good Medicine, Mark Paul walks us through the real-time function of life-saving medical devices—how they work, what they do in the body, and why timing is everything. Watch the full episode now — youtube.com/@GoodMedicineP…

This week on Good Medicine, Mark Paul shares how innovations in the medical device field are making high-quality care more accessible—especially for people and communities that have historically been underserved. Watch now on YouTube: youtube.com/@GoodMedicineP…